Protein modification, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000974 | Prp19 complex | 2 | 11 |
GO:0005681 | spliceosomal complex | 3 | 11 |
GO:0005840 | ribosome | 5 | 6 |
GO:0032991 | protein-containing complex | 1 | 11 |
GO:0043226 | organelle | 2 | 6 |
GO:0043228 | non-membrane-bounded organelle | 3 | 6 |
GO:0043229 | intracellular organelle | 3 | 6 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
GO:0140513 | nuclear protein-containing complex | 2 | 11 |
GO:1990904 | ribonucleoprotein complex | 2 | 11 |
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0005684 | U2-type spliceosomal complex | 4 | 1 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0071006 | U2-type catalytic step 1 spliceosome | 4 | 1 |
GO:0071012 | catalytic step 1 spliceosome | 3 | 1 |
GO:1902494 | catalytic complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8IGJ0
Term | Name | Level | Count |
---|---|---|---|
GO:0000209 | protein polyubiquitination | 8 | 11 |
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 11 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 11 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006259 | DNA metabolic process | 4 | 11 |
GO:0006281 | DNA repair | 5 | 11 |
GO:0006396 | RNA processing | 6 | 11 |
GO:0006397 | mRNA processing | 7 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0008380 | RNA splicing | 7 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0016070 | RNA metabolic process | 5 | 11 |
GO:0016071 | mRNA metabolic process | 6 | 11 |
GO:0016567 | protein ubiquitination | 7 | 11 |
GO:0019538 | protein metabolic process | 3 | 11 |
GO:0032446 | protein modification by small protein conjugation | 6 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0036211 | protein modification process | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0043412 | macromolecule modification | 4 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0070534 | protein K63-linked ubiquitination | 9 | 11 |
GO:0070647 | protein modification by small protein conjugation or removal | 5 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004842 | ubiquitin-protein transferase activity | 4 | 11 |
GO:0016740 | transferase activity | 2 | 11 |
GO:0019787 | ubiquitin-like protein transferase activity | 3 | 11 |
GO:0061630 | ubiquitin protein ligase activity | 5 | 11 |
GO:0061659 | ubiquitin-like protein ligase activity | 4 | 11 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 11 |
GO:0016746 | acyltransferase activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.374 |
CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.348 |
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.414 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 418 | 422 | PF00082 | 0.420 |
DEG_APCC_DBOX_1 | 417 | 425 | PF00400 | 0.361 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.478 |
DEG_SPOP_SBC_1 | 193 | 197 | PF00917 | 0.390 |
DOC_ANK_TNKS_1 | 234 | 241 | PF00023 | 0.334 |
DOC_ANK_TNKS_1 | 438 | 445 | PF00023 | 0.442 |
DOC_MAPK_DCC_7 | 418 | 426 | PF00069 | 0.365 |
DOC_MAPK_HePTP_8 | 6 | 18 | PF00069 | 0.451 |
DOC_MAPK_MEF2A_6 | 9 | 18 | PF00069 | 0.446 |
DOC_USP7_MATH_1 | 14 | 18 | PF00917 | 0.307 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.623 |
DOC_USP7_MATH_1 | 181 | 185 | PF00917 | 0.516 |
DOC_USP7_MATH_1 | 194 | 198 | PF00917 | 0.437 |
DOC_USP7_MATH_1 | 200 | 204 | PF00917 | 0.510 |
DOC_USP7_MATH_1 | 215 | 219 | PF00917 | 0.587 |
DOC_USP7_MATH_1 | 351 | 355 | PF00917 | 0.289 |
DOC_USP7_MATH_1 | 59 | 63 | PF00917 | 0.656 |
DOC_WW_Pin1_4 | 179 | 184 | PF00397 | 0.610 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.374 |
LIG_14-3-3_CanoR_1 | 275 | 284 | PF00244 | 0.345 |
LIG_14-3-3_CanoR_1 | 3 | 11 | PF00244 | 0.390 |
LIG_14-3-3_CanoR_1 | 461 | 469 | PF00244 | 0.520 |
LIG_14-3-3_CanoR_1 | 96 | 106 | PF00244 | 0.505 |
LIG_Actin_WH2_2 | 116 | 133 | PF00022 | 0.475 |
LIG_Actin_WH2_2 | 465 | 480 | PF00022 | 0.398 |
LIG_BIR_III_2 | 432 | 436 | PF00653 | 0.355 |
LIG_BRCT_BRCA1_1 | 219 | 223 | PF00533 | 0.371 |
LIG_BRCT_BRCA1_1 | 392 | 396 | PF00533 | 0.407 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.466 |
LIG_FHA_1 | 249 | 255 | PF00498 | 0.423 |
LIG_FHA_1 | 271 | 277 | PF00498 | 0.291 |
LIG_FHA_1 | 330 | 336 | PF00498 | 0.475 |
LIG_FHA_1 | 472 | 478 | PF00498 | 0.379 |
LIG_FHA_1 | 490 | 496 | PF00498 | 0.287 |
LIG_FHA_2 | 317 | 323 | PF00498 | 0.479 |
LIG_FHA_2 | 343 | 349 | PF00498 | 0.454 |
LIG_FHA_2 | 465 | 471 | PF00498 | 0.397 |
LIG_FHA_2 | 74 | 80 | PF00498 | 0.491 |
LIG_LIR_LC3C_4 | 446 | 449 | PF02991 | 0.303 |
LIG_LIR_Nem_3 | 84 | 88 | PF02991 | 0.410 |
LIG_Rb_LxCxE_1 | 339 | 354 | PF01857 | 0.440 |
LIG_RPA_C_Fungi | 201 | 213 | PF08784 | 0.375 |
LIG_SH2_CRK | 352 | 356 | PF00017 | 0.282 |
LIG_SH2_NCK_1 | 506 | 510 | PF00017 | 0.433 |
LIG_SH2_STAP1 | 352 | 356 | PF00017 | 0.398 |
LIG_SH2_STAP1 | 506 | 510 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.351 |
LIG_SH3_3 | 145 | 151 | PF00018 | 0.441 |
LIG_SH3_3 | 417 | 423 | PF00018 | 0.403 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.354 |
LIG_SUMO_SIM_par_1 | 14 | 20 | PF11976 | 0.448 |
LIG_SUMO_SIM_par_1 | 315 | 322 | PF11976 | 0.432 |
LIG_SUMO_SIM_par_1 | 332 | 341 | PF11976 | 0.411 |
LIG_TRAF2_1 | 137 | 140 | PF00917 | 0.611 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.320 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.645 |
MOD_CK1_1 | 204 | 210 | PF00069 | 0.424 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.422 |
MOD_CK1_1 | 300 | 306 | PF00069 | 0.363 |
MOD_CK1_1 | 463 | 469 | PF00069 | 0.558 |
MOD_CK1_1 | 62 | 68 | PF00069 | 0.542 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.309 |
MOD_CK2_1 | 24 | 30 | PF00069 | 0.316 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.407 |
MOD_CK2_1 | 318 | 324 | PF00069 | 0.365 |
MOD_CK2_1 | 342 | 348 | PF00069 | 0.421 |
MOD_CK2_1 | 464 | 470 | PF00069 | 0.435 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.390 |
MOD_GlcNHglycan | 177 | 180 | PF01048 | 0.499 |
MOD_GlcNHglycan | 19 | 22 | PF01048 | 0.390 |
MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.605 |
MOD_GlcNHglycan | 203 | 206 | PF01048 | 0.531 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.296 |
MOD_GlcNHglycan | 224 | 227 | PF01048 | 0.473 |
MOD_GlcNHglycan | 266 | 269 | PF01048 | 0.299 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.386 |
MOD_GlcNHglycan | 324 | 327 | PF01048 | 0.473 |
MOD_GlcNHglycan | 340 | 343 | PF01048 | 0.344 |
MOD_GlcNHglycan | 392 | 395 | PF01048 | 0.285 |
MOD_GlcNHglycan | 396 | 399 | PF01048 | 0.266 |
MOD_GlcNHglycan | 429 | 432 | PF01048 | 0.425 |
MOD_GlcNHglycan | 462 | 465 | PF01048 | 0.518 |
MOD_GlcNHglycan | 479 | 482 | PF01048 | 0.386 |
MOD_GlcNHglycan | 489 | 492 | PF01048 | 0.484 |
MOD_GlcNHglycan | 65 | 68 | PF01048 | 0.527 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.521 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.450 |
MOD_GSK3_1 | 200 | 207 | PF00069 | 0.513 |
MOD_GSK3_1 | 282 | 289 | PF00069 | 0.353 |
MOD_GSK3_1 | 318 | 325 | PF00069 | 0.335 |
MOD_GSK3_1 | 329 | 336 | PF00069 | 0.327 |
MOD_GSK3_1 | 338 | 345 | PF00069 | 0.274 |
MOD_GSK3_1 | 382 | 389 | PF00069 | 0.395 |
MOD_GSK3_1 | 390 | 397 | PF00069 | 0.257 |
MOD_GSK3_1 | 460 | 467 | PF00069 | 0.440 |
MOD_GSK3_1 | 485 | 492 | PF00069 | 0.354 |
MOD_GSK3_1 | 59 | 66 | PF00069 | 0.527 |
MOD_N-GLC_1 | 4 | 9 | PF02516 | 0.389 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.485 |
MOD_NEK2_1 | 337 | 342 | PF00069 | 0.437 |
MOD_NEK2_1 | 462 | 467 | PF00069 | 0.489 |
MOD_NEK2_1 | 477 | 482 | PF00069 | 0.263 |
MOD_NEK2_1 | 505 | 510 | PF00069 | 0.409 |
MOD_NEK2_2 | 14 | 19 | PF00069 | 0.448 |
MOD_PIKK_1 | 181 | 187 | PF00454 | 0.391 |
MOD_PIKK_1 | 256 | 262 | PF00454 | 0.326 |
MOD_PIKK_1 | 297 | 303 | PF00454 | 0.410 |
MOD_PIKK_1 | 4 | 10 | PF00454 | 0.359 |
MOD_PIKK_1 | 97 | 103 | PF00454 | 0.382 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.379 |
MOD_PKA_2 | 382 | 388 | PF00069 | 0.473 |
MOD_PKA_2 | 460 | 466 | PF00069 | 0.381 |
MOD_Plk_1 | 24 | 30 | PF00069 | 0.316 |
MOD_Plk_1 | 270 | 276 | PF00069 | 0.304 |
MOD_Plk_1 | 59 | 65 | PF00069 | 0.545 |
MOD_Plk_2-3 | 239 | 245 | PF00069 | 0.359 |
MOD_Plk_4 | 282 | 288 | PF00069 | 0.540 |
MOD_Plk_4 | 374 | 380 | PF00069 | 0.379 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.367 |
MOD_ProDKin_1 | 179 | 185 | PF00069 | 0.603 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.386 |
TRG_ENDOCYTIC_2 | 352 | 355 | PF00928 | 0.286 |
TRG_ER_diArg_1 | 155 | 157 | PF00400 | 0.443 |
TRG_NLS_Bipartite_1 | 156 | 173 | PF00514 | 0.373 |
TRG_NLS_MonoExtC_3 | 168 | 173 | PF00514 | 0.444 |
TRG_NLS_MonoExtN_4 | 166 | 173 | PF00514 | 0.436 |
TRG_Pf-PMV_PEXEL_1 | 26 | 30 | PF00026 | 0.293 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IMA9 | Leptomonas seymouri | 64% | 100% |
A0A0S4J7B3 | Bodo saltans | 35% | 100% |
A0A1X0NFA4 | Trypanosomatidae | 35% | 100% |
A0A3R7NBE4 | Trypanosoma rangeli | 35% | 100% |
A4HG28 | Leishmania braziliensis | 83% | 100% |
A4I350 | Leishmania infantum | 100% | 100% |
C9ZJM1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
E9ACW8 | Leishmania major | 98% | 100% |
E9AZF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
O22785 | Arabidopsis thaliana | 28% | 98% |
Q08E38 | Bos taurus | 30% | 100% |
Q10051 | Caenorhabditis elegans | 28% | 100% |
Q5ZMA2 | Gallus gallus | 30% | 100% |
Q94BR4 | Arabidopsis thaliana | 26% | 98% |
Q99KP6 | Mus musculus | 29% | 100% |
Q9AV81 | Oryza sativa subsp. japonica | 26% | 97% |
Q9JMJ4 | Rattus norvegicus | 29% | 100% |
Q9UMS4 | Homo sapiens | 30% | 100% |